Showing results (291-300 of 432) with videos related to

Sort By:
Pageof 44
Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.
American Journal of Hematology|January 7, 2026
Hematologic Landscape of Adult Patients With Diamond-Blackfan Anemia SyndromeNicolas Lecornec, Flore Sicre de Fontbrune, Edouard Forcade, et al.
The Lancet. Oncology|March 13, 2016
Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trialGuillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, et al.
Blood|November 19, 2005
V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosisPeter J Campbell, Martin Griesshammer, Konstanze Döhner, et al.
The Lancet. Haematology|August 4, 2018
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort studyAshley A Basiorka, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
Blood|July 15, 2011
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5qPierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag, et al.
Journal of Clinical Medicine|December 10, 2021
USAID Associated with Myeloid Neoplasm and VEXAS Syndrome: Two Differential Diagnoses of Suspected Adult Onset Still's Disease in Elderly PatientsMarion Delplanque, Achille Aouba, Pierre Hirsch, et al.
Leukemia Research|January 27, 2009
When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients? (Results of the French Belgian Swiss APL Group)Bruno Cassinat, Stéphane de Botton, Charikleia Kelaidi, et al.
Annals of Hematology|May 21, 2017
Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordanceLouise de Swart, Alex Smith, Marius MacKenzie, et al.
Blood|October 18, 2007
Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experienceSophie Park, Sophie Grabar, Charikleia Kelaidi, et al.
Pageof 44